Physician profile
Nikhil Gupta
NPI 1912298381
$5,211.26
in general payments reported to CMS, 2019-2025
33 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $35.33 · 2021: $260 · 2022: $703 · 2023: $750 · 2024: $799 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,104.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,000.26 | 2019 | |
| Sumitomo Pharma America, INC. | $668.50 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $522.92 | 2021-2025 | Erleada, Tremfya |
| Urogen Pharma, INC. | $307.35 | 2023-2025 | Jelmyto |
| Astellas Pharma US INC | $287.46 | 2021-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $264.71 | 2021-2025 | |
| Coloplast Corp | $192.90 | 2020-2025 | Speedicath |
| Teleflex LLC | $191.46 | 2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $162.83 | 2021-2024 | Edex, Xiaflex, Aveed |
| Boston Scientific Corporation | $162.29 | 2019-2024 | Ams 700 |
| Urovant Sciences INC | $152.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.54 | 2022-2025 | |
| Endo USA, INC. | $144.93 | 2024-2025 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $120.85 | 2024-2025 | Prolaris |
| Tolmar, INC. | $111.27 | 2023-2025 | Jatenzo, Eligard |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $100.29 | 2023-2025 | Pylarify |
| Hollister Incorporated | $81.50 | 2022-2024 | Vapro Pocket |
| Myovant Sciences INC. | $74.53 | 2022 | |
| Dendreon Pharmaceuticals LLC | $63.31 | 2022-2025 | Provenge |
| Merck Sharp & Dohme LLC | $61.14 | 2021-2024 | Lynparza, Keytruda |
| Blue Earth Diagnostics | $52.83 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $49.83 | 2023-2025 | Lynparza |
| Telix Pharmaceuticals | $38.24 | 2024-2025 | Illuccix |
| Ferring Pharmaceuticals INC. | $36.70 | 2025 | Adstiladrin |
| Abc Home Medical Supply, INC. | $35.82 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $34.17 | 2025 | |
| 180 Medical, INC. | $27.47 | 2022 | |
| Axonics, INC. | $24.25 | 2023 | Bulkamid, Axonics |
| Accord Healthcare, INC. | $21.88 | 2025 | |
| Dentsply Ih Ab | $21.49 | 2023 | Lofric |
| Sun Pharmaceutical Industries INC. | $18.18 | 2025 | |
| Calyxo, INC. | $17.89 | 2025 | Cvac Aspiration System |
| Dentsply Ih INC. | $15.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.